Atrial natriuretic peptide levels in rheumatic mitral regurgitation and response to angiotensin-converting enzyme inhibitors


Kula S. , Tunaoglu F., Olgunturk R., Gokcora N.

CANADIAN JOURNAL OF CARDIOLOGY, cilt.19, ss.405-408, 2003 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 19 Konu: 4
  • Basım Tarihi: 2003
  • Dergi Adı: CANADIAN JOURNAL OF CARDIOLOGY
  • Sayfa Sayıları: ss.405-408

Özet

BACKGROUND: Rheumatic mitral regurgitation (MR) causes heart failure by volume overload and an increase in atrial natriuretic peptide (ANP) levels by atrial stretching. Symptoms of heart failure improve with ANP treatment. Angiotensin-converting enzyme inhibitors (ACEI) and ANP have similar effects, such as vasodilation, natriuresis and diuresis.